• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺激响应型黏附益生菌通过清除活性氧和调节肠道菌群治疗炎症性肠病。

Stimulation-responsive mucoadhesive probiotics for inflammatory bowel disease treatment by scavenging reactive oxygen species and regulating gut microbiota.

机构信息

Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, PR China.

Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, PR China.

出版信息

Biomaterials. 2023 Oct;301:122274. doi: 10.1016/j.biomaterials.2023.122274. Epub 2023 Aug 12.

DOI:10.1016/j.biomaterials.2023.122274
PMID:37586233
Abstract

Inflammatory bowel disease (IBD) is characterized by the high level of reactive oxygen species (ROS) and highly dysfunctional intestinal flora. Here, a stimulation-responsive mucoadhesive probiotic Lac@HDP was rationally constructed for achieving specific adhesion of colitis site and depleting high level of ROS in inflammatory site. Briefly, Lac is Lactobacillus acidophilus, HDP is obtained by hyaluronic acid grafted with dopamine protected by phenylboric acid. Specifically, by consuming a large amount of ROS, phenyl borate group of Lac@HDP is oxidized and fractured, thus exposing the catechol hydroxyl group and obtaining strong mucosal adhesion ability, thereby significantly prolong the retention time of Lac in the inflammatory site. In the murine model of acute and chronic colitis, the stimulation-responsive mucoadhesive probiotics were significantly more effective in alleviating colitis symptoms than antioxidants and probiotics alone. In addition, the abundance and diversity of intestinal flora were increased after treatment with Lac@HDP, which was helpful to alleviate IBD. Importantly, the stimulation-responsive mucoadhesive probiotics have good biological safety in vivo, which provides the prospect of clinical application in the future.

摘要

炎症性肠病(IBD)的特征是活性氧(ROS)水平高和肠道菌群功能失调。在这里,合理构建了一种刺激响应型黏附益生菌 Lac@HDP,以实现结肠炎部位的特异性黏附和炎症部位高水平 ROS 的耗竭。简单来说,Lac 是嗜酸乳杆菌,HDP 是通过透明质酸接枝多巴胺获得的,由苯硼酸保护。具体来说,通过消耗大量的 ROS,Lac@HDP 的苯硼酸基团被氧化和断裂,从而暴露出儿茶酚羟基基团,并获得强大的黏膜黏附能力,从而显著延长 Lac 在炎症部位的保留时间。在急性和慢性结肠炎的小鼠模型中,刺激响应型黏附益生菌在缓解结肠炎症状方面比单独使用抗氧化剂和益生菌更有效。此外,Lac@HDP 治疗后增加了肠道菌群的丰度和多样性,有助于缓解 IBD。重要的是,刺激响应型黏附益生菌在体内具有良好的生物安全性,为其未来的临床应用提供了前景。

相似文献

1
Stimulation-responsive mucoadhesive probiotics for inflammatory bowel disease treatment by scavenging reactive oxygen species and regulating gut microbiota.刺激响应型黏附益生菌通过清除活性氧和调节肠道菌群治疗炎症性肠病。
Biomaterials. 2023 Oct;301:122274. doi: 10.1016/j.biomaterials.2023.122274. Epub 2023 Aug 12.
2
Clickable nanozyme enhances precise colonization of probiotics for ameliorating inflammatory bowel disease.点击纳米酶增强益生菌的精准定植以改善炎症性肠病。
J Control Release. 2024 Sep;373:749-765. doi: 10.1016/j.jconrel.2024.07.064. Epub 2024 Aug 2.
3
Attenuation of inflammatory bowel disease by oral administration of mucoadhesive polydopamine-coated yeast β-glucan via ROS scavenging and gut microbiota regulation.通过 ROS 清除和肠道微生物群调节的口服黏附性聚多巴胺包覆酵母β-葡聚糖来减轻炎症性肠病。
J Nanobiotechnology. 2024 Apr 12;22(1):166. doi: 10.1186/s12951-024-02434-3.
4
ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease.ROS 清除和炎症靶向聚多巴胺纳米颗粒调节炎症性肠病中的肠道免疫和菌群治疗。
Acta Biomater. 2023 Apr 15;161:250-264. doi: 10.1016/j.actbio.2023.02.026. Epub 2023 Mar 1.
5
Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice.益生菌鸡尾酒通过改善结肠炎小鼠的肠道微生物群和代谢物来缓解肠道炎症。
Front Cell Infect Microbiol. 2022 Jun 15;12:886061. doi: 10.3389/fcimb.2022.886061. eCollection 2022.
6
Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota.双歧杆菌和乳杆菌通过调节肠道黏膜屏障和微生物群改善不同年龄斑马鱼的炎症性肠病。
Life Sci. 2023 Jul 1;324:121699. doi: 10.1016/j.lfs.2023.121699. Epub 2023 Apr 14.
7
Semi-Rational Screening of Probiotics from the Fecal Flora of Healthy Adults against DSS-Induced Colitis Mice by Enhancing Anti-Inflammatory Activity and Modulating the Gut Microbiota.通过增强抗炎活性和调节肠道微生物群,从健康成年人粪便菌群中筛选对 DSS 诱导的结肠炎小鼠有半理性作用的益生菌。
J Microbiol Biotechnol. 2019 Sep 28;29(9):1478-1487. doi: 10.4014/jmb.1807.06061.
8
ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis.ROS 响应性透明质酸水凝胶用于靶向递送益生菌以缓解结肠炎。
Int J Biol Macromol. 2022 Dec 1;222(Pt A):1476-1486. doi: 10.1016/j.ijbiomac.2022.09.247. Epub 2022 Oct 1.
9
Effects of probiotics and prebiotics on intestinal microbiota in mice with acute colitis based on 16S rRNA gene sequencing.基于 16S rRNA 基因测序的益生菌和益生元对急性结肠炎小鼠肠道微生物群的影响。
Chin Med J (Engl). 2019 Aug 5;132(15):1833-1842. doi: 10.1097/CM9.0000000000000308.
10
Probiotic mixtures with aerobic constituent promoted the recovery of multi-barriers in DSS-induced chronic colitis.含需氧成分的益生菌混合物促进了 DSS 诱导的慢性结肠炎中多重屏障的恢复。
Life Sci. 2020 Jan 1;240:117089. doi: 10.1016/j.lfs.2019.117089. Epub 2019 Nov 20.

引用本文的文献

1
Engineering the Microbiome: a Novel Approach to Managing Autoimmune Diseases.工程化微生物群:一种治疗自身免疫性疾病的新方法。
Neuromolecular Med. 2025 Sep 5;27(1):63. doi: 10.1007/s12017-025-08879-5.
2
Bioactive Polysaccharides Prevent Lipopolysaccharide-Induced Intestinal Inflammation via Immunomodulation, Antioxidant Activity, and Microbiota Regulation.生物活性多糖通过免疫调节、抗氧化活性和微生物群调节预防脂多糖诱导的肠道炎症。
Foods. 2025 Jul 23;14(15):2575. doi: 10.3390/foods14152575.
3
Probiotic-Enhanced Porous Bio-Hybrids with Inflammatory Targeting, ROS Scavenging, and Long-Term Drug Release for Ulcerative Colitis Treatment.
用于溃疡性结肠炎治疗的具有炎症靶向、活性氧清除和长期药物释放功能的益生菌增强型多孔生物杂交体。
Adv Sci (Weinh). 2025 Aug;12(32):e04802. doi: 10.1002/advs.202504802. Epub 2025 Jun 27.
4
Modified probiotics and the related combinatorial therapeutics.改良益生菌及相关联合疗法。
Acta Pharm Sin B. 2025 May;15(5):2431-2453. doi: 10.1016/j.apsb.2025.03.021. Epub 2025 Mar 14.
5
Microfluidics-Based Microcarriers for Live-Cell Delivery.用于活细胞递送的基于微流控技术的微载体
Adv Sci (Weinh). 2025 May;12(18):e2414410. doi: 10.1002/advs.202414410. Epub 2025 Apr 4.
6
Multi-functionalized probiotics through layer-by-layer coating with tannic acid-Mg and casein phosphopeptide complexes for preventing ulcerative colitis.通过用单宁酸-镁和酪蛋白磷酸肽复合物逐层包被制备多功能益生菌用于预防溃疡性结肠炎
Mater Today Bio. 2025 Feb 27;31:101621. doi: 10.1016/j.mtbio.2025.101621. eCollection 2025 Apr.
7
Evaluating the anti-inflammatory and antioxidant efficacy of complementary and alternative medicines (CAM) used for management of inflammatory bowel disease: a comprehensive review.评估用于治疗炎症性肠病的补充和替代医学(CAM)的抗炎和抗氧化功效:一项综述。
Redox Rep. 2025 Dec;30(1):2471737. doi: 10.1080/13510002.2025.2471737. Epub 2025 Mar 8.
8
Probiotic nanocomposite materials with excellent resistance, inflammatory targeting, and multiple efficacies for enhanced treatment of colitis in mice.具有优异抗性、炎症靶向性和多种功效的益生菌纳米复合材料,用于增强小鼠结肠炎的治疗效果。
J Nanobiotechnology. 2025 Mar 8;23(1):188. doi: 10.1186/s12951-025-03240-1.
9
016 Alleviates Mice Colitis by Modulating Oxidative Stress, Gut Microbiota, and Microbial Metabolism.016 通过调节氧化应激、肠道微生物群和微生物代谢减轻小鼠结肠炎。
Nutrients. 2025 Jan 26;17(3):452. doi: 10.3390/nu17030452.
10
Microbiota governs host chenodeoxycholic acid glucuronidation to ameliorate bile acid disorder induced diarrhea.微生物群调控宿主鹅去氧胆酸葡萄糖醛酸化,以改善胆汁酸紊乱引起的腹泻。
Microbiome. 2025 Feb 4;13(1):36. doi: 10.1186/s40168-024-02011-8.